criteria for glp 1 va use The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions The GLP-1 Knowledge Gap GLP-1 Weight Loss Eligibility: Medical

Starvation-induced phosphorylation of HNF4 by Protein Kinase A decreases DNA binding and reduces transcriptional activity 64

An earlier, smaller trial found that VK2735 helped users achieve an average weight loss of 14% from baseline numbers, plus 13% compared with a placebo after 13 weeks of treatment

Even though a promising candidate for lifespan extension and SASP repression, multiple side effects including metabolic dysregulation, impaired wound healing, and hyperlipidemia have been reported (85)

This research does not address programs that seek to deprescribe GLP-1 medications, since peer reviewed studies of such programs are not yet available